Growth in Biological Technology

AEterna Zentaris to Present at Upcoming Canaccord Adams 29th Annual Global Growth Conference

QUEBEC CITY, Aug. 6 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS , TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its President and CEO, Juergen Engel, Ph.D., will present a corporate overview at the upcoming Canaccor...

Orexigen(R) Therapeutics to Speak at Canaccord Adams Global Growth Conference

SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment of obesity, today announced that the Company will be speaking at the 29th Annual Canaccord Adams Global Growth Conference. The details are as fol...

VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference

MOUNTAIN VIEW, Calif., Aug. 4 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS ), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that Timothy Morris, chief financial officer, will present an overview of the ...

Optimer Pharmaceuticals to Present at the Canaccord Adams 29th Annual Global Growth Conference

SAN DIEGO, Aug. 4 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) is scheduled to present at the Canaccord Adams 29th Annual Global Growth Conference at the Intercontinental Hotel in Boston on August 13, 2009, 2:00 p.m. Eastern Time. (Logo: http://w...

Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors

SAN DIEGO, July 30 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM ) today announced plans to develop a DNA-based orthobiologics product portfolio based on research and development by Cardium's Tissue Repair Company that will initially focus on non-union bone fractu...

NovaBay(R) Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference

EMERYVILLE, Calif., July 27 /PRNewswire-FirstCall/ -- NovaBay(R) Pharmaceuticals, Inc. (NYSE-AMEX: NBY ) ( http://www.novabaypharma.com ), a clinical stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a wide range of bacterial,...

Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan

MUMBAI, July 24 /PRNewswire/ -- - Frost & Sullivan's Food & Beverage Focus 2009 Annual Executive MindXchange on Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector The Indian food processing industry has seen some spectacular product devel...

Peregrine Pharmaceuticals to Present at the Jesup & Lamont 2009 Growth Stock & National Sales Conference

TUSTIN, Calif., July 23 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that senior management will present at the Jesup & Lamont 2009 Growth Stock & National Sales Conference on Thursday, July 30, 2009 at 8:30 am EDT at the Boca Raton ...

OpenQ Posts a 200% Revenue Growth in the First Half of 2009

OpenQ announces solid revenue growth for the first half of 2009 and is now serving 7 of the Top 10 pharmaceutical and 3 of the Top 5 medical device companies. Charlottesville, VA, San Diego, CA, New York, NY and Paris, France (PRWEB) July 18, 2009 -- OpenQ, a leading pr...

STALLERGENES: Strong Sales Growth in 1st Half-Year: up 12% Full-Year Guidance Maintained

ANTONY, France, July 15 /PRNewswire-FirstCall/ -- Million EUR 2008 08/07 2009 09/08 MEUR %Sales Var.% MEUR %Sales Var.% Southern Europe (1) 26.7 71 15 28.5 68 7 Other EU countries (2) 9.3 24 20...

Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference

NEW YORK, July 13 /PRNewswire-FirstCall/ -- Jesup & Lamont, Inc., (Amex: JLI ), a full-service boutique brokerage and investment banking firm serving retail and institutional clients, today announced the LifeTech Capital Group companies presenting at its 2009 Growth Stock & National Sale...

PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin

NES-ZIONA, Israel, June 30 /PRNewswire-FirstCall/ -- PROLOR Biotech, Inc. (OTC Bulletin Board: PBTH), formerly Modigene Inc., today announced that the U. S. Patent and Trademark Office (PTO) has issued two new patents for the company's long-acting CTP-enhanced human growth hormone (hGH-CTP) and hu...

Leading for Growth in the New Economic Reality Includes Vision and Innovation

DuPont CEO Ellen Kullman outlines leading in a dynamic and unpredictable world at Wharton Leadership Conference. Philadelphia, PA (Vocus) June 16, 2009 -- As the global recession has changed the landscape of many markets DuPont serves, the company is well-positioned t...

AEterna Zentaris Acquires All Assets from Ardana for Growth Hormone Secretagogue Compound, AEZS-130

All amounts are in US dollars QUEBEC CITY, June 8 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported that after regaining from Ardana Biosciences Ltd. ("Ardana"), the worldwid...

Express Scripts to Present at William Blair Growth Stock Conference

ST. LOUIS, June 5 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX ) announced that it will present at the William Blair Growth Stock Conference on Thursday, June 11, 2009 at 8:00 a.m. CT at the Four Seasons Hotel in Chicago. This presentation will also be broadcast via th...

Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009

NEW YORK, May 27 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. ("Biostar" or the "Company") (OTC Bulletin Board: BSPM) today reported financial results for the three months ended March 31, 2009. The Company reported revenue of $7,447,664 for the quarter ended March 31, 20...

Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business

LAVAL, QC, May 19 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) today reports its consolidated financial results for the fiscal year ended February 28, 2009. Neptune reports record revenues, EBITDA(1) and first-time profitability for t...

Healthy Advice Networks Achieves Strong Growth Despite Challenging Economy

Attributed to Delivering Business Results for Sponsoring Brands CINCINNATI, May 12 /PRNewswire/ -- Healthy Advice Networks , the nation's leading provider of physician office-based patient-education programs, announces another record performance in 2008. In a challenging economic climate, t...

Sigma-Aldrich to Present at the Baird 2009 Growth Stock Conference on Tuesday, May 12, 2009

ST. LOUIS, May 7 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL ) will be presenting at the Baird 2009 Growth Stock Conference on Tuesday, May 12th at 11:15 AM Central Daylight Time in Chicago, IL. Interested parties may listen via live audio broadcast over the Internet availa...

BioMarin to Present at the Baird Growth Stock Conference

NOVATO, Calif., May 7 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that Joshua Grass, Vice President of Business and Corporate Development of BioMarin, will present a company update at the Baird Growth Stock Conference in Chicago on Thursday, May 14, 200...

CRO Acquisition Seen Boosting Activity, Positioning ASG, Inc., for New Growth in Q2

CARY, N.C., May 5 /PRNewswire/ -- ASG, Inc., saw continued growth in the first quarter following its acquisition of neighboring Ockham Development Group. The February merger with the full-service contract research organization sought to expand the breadth and value of services that Cary, Nor...

Bio-Matrix Scientific Group CEO Tells Wall Street Transcript That 'Positive Cash Flow' Is Possible in '09; New Stem Cell Banking Facility Is Growth Vehicle Over the Next Two Years, Says CEO in Exclusive News Interview

SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- David Koos, Chairman and CEO of San Diego-based Bio-Matrix Scientific Group Inc. (OTC Bulletin Board: BMSN), told the editors of The Wall Street Transcript, a New York City financial news weekly, that there is an excellent possibility that the company ...

CryoLife to Present at Sidoti's 13th Annual New York Emerging Growth Institutional Forum

ATLANTA, March 19 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and tissue processing company, announced today that it will participate in the Sidoti & Company, LLC 13th Annual New York Emerging Growth Institutional Forum at The Grand Hyatt...

RainDance Technologies Reviews Opportunities for Growth at Cowen Health Care Conference

BOSTON, March 17 /PRNewswire/ -- RainDance Technologies, Inc., a privately held provider of innovative microdroplet-based solutions for human health and disease research, today announced it will be shipping its first commercial Sequence Enrichment Solution this month and reviewed the company's opp...

Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe

However, Off-Label Use of Avastin Will Take Market Share Away from Lucentis from 2012 to 2017, According to a New Report from Decision Resources WALTHAM, Mass., March 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcar...

Monsanto's Historic R&D Investment has Contributed to Mid-20s Gross Profit Growth for Its Seeds and Genomics Segment

Drought-Tolerance Technology Crosses Another Key Regulatory Milestone LONDON, March 10 /PRNewswire-FirstCall/ -- Monsanto's historic investment in research and development in breeding and biotechnology has contributed to a 24 percent compound annual growth rate for the company's Seeds and G...

Bone Biologics Announces UCB-1 (NELL-1) Bone Growth Protein Production Process With Aragen Biosciences

Produces 98% pure protein THOUSAND OAKS, Calif., Feb. 24 /PRNewswire/ -- Bone Biologics, Inc. announced today that it's contract research and development organization, Aragen Bioscience, has completed development of a recombinant cell line and initial production process for UCB-1 (NELL-1) rec...

iCardiac Reports Significant Revenue Growth and Profitability

iCardiac Continues to Successfully Leverage Differentiated Service and Product Offering Rochester, New York (PRWEB) February 23, 2009 -- iCardiac Technologies, Inc., a leading innovator in advanced cardiac safety biomakers and automated QT analysis, today announced that...

Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion

PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, February 19 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ) the global specialty biopharmaceutical company announces results for the year to December 31, 2008 - a year which has seen significant growth in Shire's new product port...

Obio Pharmaceutical Announces Product Growth Strategy

HONG KONG, Feb. 18 /PRNewswire-Asia/ -- Obio Pharmaceutical Holdings Ltd ("Obio"/ "the Company") announced its business growth ticket to the international pharmaceutical arena. With a strong product pipeline in drug development, backed up by strong international investors including Yangtze Ven...

Frost & Sullivan Forecasts Early Rebound: Strong Growth Ahead for Global Economy

MOUNTAIN VIEW, Calif., Feb. 17 /PRNewswire/ -- Frost & Sullivan, the Growth Partnership Company, reaffirms its position that the economy is regaining its strength, thanks in part to an unprecedented US $1 trillion stimulus package from the US government and additional stimulus packages fro...

Following a Record Year in 2008 Gerresheimer Again Sets its Sights on Substantial Growth in 2009

DUSSELDORF, Germany, February 17 /PRNewswire/ -- - Sales Grow by 10.7% to EUR1.06bn - Adjusted Earnings per Share Improves by 36.6% From EUR1.34 Euro to EUR1.83 - Adjusted EBITDA Margin Rises From 19.0 to 19.5% - CEO Dr. Axel Herberg: "Following the record year in 200...

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference

SAN DIEGO, Feb. 10 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's Presi...

China-Biotics, Inc. to Present at Roth Capital Partners 21st Annual OC Growth Stock Conference

SHANGHAI, China, Feb. 10 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT ) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced members of the Compa...

Monsanto Executives to Discuss Company's Growth Drivers, Profit Goals at Investor Conferences in February

ST. LOUIS, Feb. 4 /PRNewswire-FirstCall/ -- On the heels of a strong start to fiscal 2009, Monsanto Company (NYSE: MON ) executives will explain to investors this month where the company sees its opportunities for continued growth through the rest of this year and how it plans to achieve its goa...

Alkemists Labs Wins Nutrition Business Journal's 2008 Industry Growth Award

Maintaining growth in the face of a recession is no small feat for any company. Last year, Alkemists Labs reaped the benefit of what company Founder Sidney Sudberg called "being in the right place at the right time" and showed year over year sales growth of 105%. ...

Secretropin(R) - Effective, Preferable, Affordable as an Alternative to Injectable Growth Hormone - Gains Momentum

ENCINO, Calif., Feb. 2 /PRNewswire/ -- Secretropin(R) , the first clinically proven natural stimulator of growth hormone production, is gaining the medical community's acceptance as a more desirable "first step" approach to pursuing hormonal balance. Although classified as a natural food suppleme...

Fadel Partners Announces 13% Growth Despite IT Services Industry Downtrend

NEW YORK, Jan. 27 /PRNewswire/ -- Technology and consulting firm, Fadel Partners Inc., a certified partner in the Oracle Partner Network, today announced year over year revenue growth of 13% for 2008, and expects to continue the positive trend in 2009. The company's report stands in contrast to a...

Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone

-hGH-CTP Development Program Has Been Approved For Second-Year Funding Through a Special Grant From the Israeli Office of the Chief Scientist- NES-ZIONA, Israel, Jan. 27 /PRNewswire-FirstCall/ -- Modigene Inc. (OTC Bulletin Board: MODG) today reported that its Israeli-based R&D subsidiary...

Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs)

TAMPA BAY, Fla., Jan. 7 /PRNewswire/ -- News briefs concerning economic and business growth in the Tampa Bay Region from the Tampa Bay Partnership: Draper Labs Acquires Manufacturing Site in Tampa Bay The Charles Stark Draper Laboratory bought a 41,000-square-foot building in St...